June 7, 2023
“Quite excited to present TheraPPI at BioValley Basel on 19 June 2023!” said Luc Otten Chief Executive Officer of TheraPPI Bioscience (“TheraPPI”), a preclinical biotechnology company developing a portfolio of small molecules modifying protein interactions in oncology, rare diseases and inflammation.
“A great opportunity to present our vision how to overcome cancer drug resistance and to provide cure to rare diseases. This is also the opportunity to celebrate BioValley for networking and fostering integration among Life Sciences Community in the Basel Region.”
…
Read in LinkedIn > https://www.linkedin.com/feed/update/urn:li:activity:7072160722587111426/